Table 1.
Demographic and clinical characteristics of 191 cases and 203 controls with coronary disease
Cases (n=191) | Controls (n=203) | p value* | |
---|---|---|---|
Age (mean ± SD) | 72 ± 12 | 67 ± 11 | 0.0002 |
Male (%) | 71% | 64% | 0.16 |
BMI (mean ± SD) | 28.7 ± 7.2 | 30.0 ± 6.9 | 0.08 |
Diabetes (%) | 49% | 34% | 0.003 |
Hypertension (%) | 81% | 74% | 0.14 |
History of atrial fibrillation / flutter | 31% | 14% | <0.0001 |
Serum creatinine, mg/dL (median, IQR)† | 1.4 (1.0 – 1.8) | 1.1 (0.9 – 1.4) | <0.0001 |
Cholesterol, mg/dL (means ± SD) ‡ | 166 ± 45 | 174 ± 50 | 0.17 |
Use of beta blockers (%) | 69% | 61% | 0.08 |
Use of ACE inhibitors (%) | 53% | 47% | 0.23 |
Use of angiotensin receptor blockers (%) | 6% | 11% | 0.08 |
Smoking§ | 0.56 | ||
Current smoker | 30% | 28% | |
Former smoker | 48% | 45% | |
Non-smoker | 22% | 27% | |
LVSD | <0.0001 | ||
Normal (EF ≥ 55%) | 26% | 54% | |
Mild to moderate (EF 36–54%) | 38% | 28% | |
Severe (EF ≤ 35%) | 36% | 19% |
EF: Ejection Fraction; LVSD: Left Ventricular Systolic Dysfunction assessed by echocardiogram
p values from independent samples t-test for continuous variables and chi-square test for categorical variables.
Creatinine values available for 175 cases and 196 controls. Due to skewed distribution, creatinine values were log-transformed for all statistical tests.
Cholesterol values available for 114 cases and 156 controls.
Smoking history available for 152 cases and 140 controls.